Until such evidence is available for retatrutide, therapies with established cardiovascular and renal benefitssuch as semaglutide, supported by SUSTAIN-6 [5] and FLOW [57] trials in people with T2D, and the SELECT trial [58] in people with obesity - should be prioritised in populations with existing cardio-renal disease
Conclusions Mechanistic and preliminary clinical evidence have consistently pointed toward beneficial effects of GLP-1 analogues and GLP-1R agonists on cardiovascular diseases in T2D patients
doi:10.1126/sciadv.adu1589 2026 The Author(s)
According to Association for the Study of Obesity data, around 90% of weight-loss medication users access Mounjaro privately and, therefore, rely on independent providers for guidance and support when making choices that have been impacted or influenced by the cost increases in recent times 2
Administration A trained professional will administer the injection, typically in the upper arm
Cn c vo thng tin bn hng sn xut, thi im ph hp nht b sung vin ung Glutathione White 800 cho c th l khi bn ang dng ba